Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine and lithium monotherapy maintenance study in bipolar I disorder
2004-000915-25Phase 3Terminated
- Sponsor
- AstraZeneca
- Start
- Feb 2005
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Seroquel monotherapy, Lithium carbonate monotherapy and Placebo (3 arms). Primary endpoint: Time to recurrence of a mood event. Started Feb 2005; status: terminated.
02
Drugs
quetiapinelithium carbonate
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2004-000915-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000915-25.